Shaolin Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.15M Sell
200,760
-17,334
-8% -$185K 0.1% 201
2026
Q1
$2.31M Hold
218,094
0.09% 183
2025
Q4
$2.29M Buy
218,094
+17,148
+9% +$179K 0.07% 170
2025
Q3
$2.08M Hold
200,946
0.09% 134
2025
Q2
$2.06M Buy
200,946
+50,946
+34% +$518K 0.07% 95
2025
Q1
$1.51M Buy
+150,000
New +$1.51M 0.06% 75

Other funds holding TDAC

Shaolin Capital Management's TDAC Position: Q2 2026 in Review

Shaolin Capital Management reduced its Translational Development Acquisition Corp (TDAC) stake by 7.9% in Q2 2026, selling an estimated $185K and leaving 200,760 shares worth $2.15M. The position accounts for 0.1% of the portfolio, ranked #201.

Shaolin Capital Management first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.31M in Q1 2026. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Shaolin Capital Management held 200,760 shares of Translational Development Acquisition Corp worth $2.15M as of Q2 2026.
  • Shaolin Capital Management sold 17,334 Translational Development Acquisition Corp shares in Q2 2026, an estimated $185K.
  • Translational Development Acquisition Corp made up 0.1% of Shaolin Capital Management's portfolio in Q2 2026, its #201 holding.
  • Shaolin Capital Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • Shaolin Capital Management's Translational Development Acquisition Corp position peaked at $2.31M in Q1 2026.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Shaolin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.